Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer

NCT00347438 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped a result of slow accrual

Conditions

Breast Cancer

Interventions

DRUG: Capecitabine

Sponsor

University of Chicago

Collaborators

[object Object]
[object Object]